BrightSpring Health Services, Inc. (NASDAQ: BTSG) priced a secondary offering of 20 million common shares at $41.15 per share on March 2, 2026. The shares are being sold by existing shareholders, including an affiliate of Kohlberg Kravis Roberts & Co. and members of management, and the company will receive no proceeds from the sale.
In parallel, BrightSpring authorized a share repurchase of 1,464,807 shares from the underwriter at the same $41.15 price. The buyback demonstrates the company’s confidence that its stock is trading at an attractive valuation and serves to offset the dilution created by the secondary offering.
The transaction follows a strong Q4 2025 earnings report in which BrightSpring posted revenue of $3.6 billion, up 29% year‑over‑year, and an adjusted EPS of $0.33 versus the consensus estimate of $0.25—a beat of $0.08. The earnings outperformance was driven by continued demand for the company’s home‑care services, margin expansion from strategic acquisitions, and disciplined cost management.
An affiliate of KKR and senior management are the primary selling shareholders, underscoring the long‑standing private‑equity relationship that has supported BrightSpring’s growth since its 2019 investment. The sale allows these stakeholders to realize gains while the company maintains its capital structure.
The secondary offering does not raise new capital for BrightSpring; instead, the concurrent buyback reflects management’s intent to return value to shareholders and to maintain a balanced capital structure. The transaction is expected to close on March 4, 2026, subject to customary closing conditions.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.